We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over…

QIAseq Expanded Carrier Screening Panel and industry-leading software identify genetic variants responsible for more than 200 disease indications Every year,…

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…

Introducing the Whole Genome Alignment Plugin Paula Tataru, Ph.D, Senior Bioinformatics Scientist The new Whole Genome Alignment plugin, available for…

Over a quarter million germline mutations catalogued HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD contains…

In a recent blog post we shared exciting news on new functionalities for detecting antimicrobial resistance (AMR) implemented within CLC…

Introduction to the Advanced Structural Variant Detection plugin for the CLC Genomics Workbench Structural variants affect large regions of the…

Introduction to the Transcript Discovery Plugin Leif Schauser, PhD, Director Product Management Genome Analysis Bioinformatics – CLC Transcript discovery using…

Find resistance through surveillance and source tracing with two new tools: PointFinder and ShortBRED Winnie Ridderberg, PhD, Senior Scientist, Microbial…

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…